Alliance Wealth Management Group Increases Stock Position in Colgate-Palmolive (NYSE:CL)

Alliance Wealth Management Group boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 73.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,981 shares of the company’s stock after buying an additional 2,101 shares during the quarter. Alliance Wealth Management Group’s holdings in Colgate-Palmolive were worth $453,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Geode Capital Management LLC lifted its position in shares of Colgate-Palmolive by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company’s stock valued at $1,868,723,000 after buying an additional 324,683 shares during the last quarter. Tradewinds LLC. lifted its position in Colgate-Palmolive by 9.8% during the fourth quarter. Tradewinds LLC. now owns 63,831 shares of the company’s stock valued at $5,539,000 after acquiring an additional 5,705 shares during the last quarter. HighPoint Advisor Group LLC boosted its stake in Colgate-Palmolive by 4.3% in the fourth quarter. HighPoint Advisor Group LLC now owns 16,330 shares of the company’s stock valued at $1,427,000 after acquiring an additional 672 shares in the last quarter. B. Metzler seel. Sohn & Co. AG grew its holdings in Colgate-Palmolive by 4.6% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 395,151 shares of the company’s stock worth $35,909,000 after purchasing an additional 17,267 shares during the last quarter. Finally, Seven Mile Advisory purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $203,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of several recent analyst reports. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, Raymond James reissued an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $101.78.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $93.84 on Tuesday. The company’s 50-day moving average is $89.80 and its two-hundred day moving average is $93.44. The firm has a market capitalization of $76.11 billion, a price-to-earnings ratio of 26.66, a PEG ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business earned $0.87 earnings per share. Analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its Board of Directors has authorized a stock buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.22%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.09%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.